{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:00:55Z","timestamp":1790197255037,"version":"4.1.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Reduction in circulating cholesterol is an important step in lowering cardiovascular risk. Although statins are the most frequently prescribed cholesterol-lowering medication, there remains a significant portion of patients who require alternative treatment options. Nutraceuticals are increasingly popular as cholesterol-lowering agents. Despite the lack of long-term trials evaluating their use on cardiovascular endpoints and mortality, several studies have demonstrated their potential cholesterol-lowering effects. The purpose of this review is to provide an update on the role of nutraceuticals as cholesterol-lowering agents. The present review will focus on individual nutraceutical compounds, which have shown modest cholesterol-lowering abilities, as well as combination nutraceuticals, which may offer potential additive and\/or synergistic effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Berberine, red yeast rice, and plant sterols have moderate potential as cholesterol-lowering agents. Combination nutraceuticals, including the proprietary formulation, Armolipid Plus, appear to confer additional benefit on plasma lipid profiles, even when taken with statins and other agents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Although robust, long-term clinical trials to examine the effects of nutraceuticals on clinical outcomes are still required, their cholesterol-lowering ability, together with their reported tolerance and safety, offer a pragmatic option for lowering plasma cholesterol levels.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000455","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T21:38:38Z","timestamp":1504129118000},"page":"495-501","source":"Crossref","is-referenced-by-count":34,"title":["Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents"],"prefix":"10.1097","volume":"28","author":[{"given":"Natalie","family":"Ward","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences & Curtin Health Innovation Research Institute, Curtin University"},{"name":"School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[{"name":"Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz"},{"name":"Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Watts","sequence":"additional","affiliation":[{"name":"School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia"},{"name":"Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijcard.2016.09.075","article-title":"Statin nonadherence and residual cardiovascular risk: there is need for substantial improvement","volume":"225","author":"Banach","year":"2016","journal-title":"Int J Cardiol"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2016.12.036","article-title":"Statin intolerance and risk of coronary heart events and all-cause mortality following myocardial infarction","volume":"69","author":"Serban","year":"2017","journal-title":"J Am College of Cardiol"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2015.00022","article-title":"Role of nutraceuticals in hypolipidemic therapy","volume":"2","author":"Barbagallo","year":"2015","journal-title":"Front Cardiovasc Med"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.nut.2016.04.007","article-title":"Lipid-modifying effects of nutraceuticals: an evidence-based approach","volume":"32","author":"Sahebkar","year":"2016","journal-title":"Nutrition"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ejim.2014.06.008","article-title":"Nutraceuticals for the treatment of hypercholesterolaemia","volume":"25","author":"Mannarino","year":"2014","journal-title":"Eur J Internal Med"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrendo.2016.210","article-title":"Functional foods and dietary supplements for the management of dyslipidaemia","volume":"13","author":"Hunter","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat Med"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0032-1328321","article-title":"The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials","volume":"79","author":"Dong","year":"2013","journal-title":"Planta Med"},{"key":"R14-20230917","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.metabol.2008.01.037","article-title":"Combination of simvastatin with berberine improves the lipid-lowering efficacy","volume":"57","author":"Kong","year":"2008","journal-title":"Metabolism"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"591654","DOI":"10.1155\/2012\/591654","article-title":"Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis","volume":"2012","author":"Dong","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1021\/jf801566r","article-title":"Cholesterol-lowering nutraceuticals and functional foods","volume":"56","author":"Chen","year":"2008","journal-title":"J Agric Food Chem"},{"key":"R17-20230917","first-page":"D99","article-title":"[\u2019Red yeast rice\u2019 as a cholesterol-lowering substance? Caution is warranted]","volume":"160","author":"Brouwers","year":"2016","journal-title":"Nederlands tijdschrift voor geneeskunde"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"101","author":"Lu","year":"2008","journal-title":"Am J Cardiol"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.atherosclerosis.2013.11.043","article-title":"Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease","volume":"232","author":"Gylling","year":"2014","journal-title":"Atherosclerosis"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","article-title":"Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis","volume":"369","author":"Yokoyama","year":"2007","journal-title":"Lancet"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjcard.2011.04.015","article-title":"Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multicenter, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial)","volume":"108","author":"Bays","year":"2011","journal-title":"Am J Cardiol"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.amjcard.2012.05.031","article-title":"Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study)","volume":"110","author":"Ballantyne","year":"2012","journal-title":"Am J Cardiol"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/clc.22692","article-title":"Rationale and design of REDUCE-IT: reduction of cardiovascular events with icosapent ethyl-intervention trial","volume":"40","author":"Bhatt","year":"2017","journal-title":"Clin Cardiol"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ctim.2014.07.006","article-title":"Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial","volume":"22","author":"Panahi","year":"2014","journal-title":"Compl Therap Med"},{"key":"R25-20230917","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ajcn\/88.1.38","article-title":"Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials","volume":"88","author":"Hooper","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/ajcn\/85.4.1148","article-title":"Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials","volume":"85","author":"Taku","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"R27-20230917","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3945\/ajcn.110.010926","article-title":"Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials","volume":"94","author":"Zheng","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.jada.2011.08.009","article-title":"Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis","volume":"111","author":"Kim","year":"2011","journal-title":"J Am Diet Assoc"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.numecd.2014.01.016","article-title":"The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials","volume":"24","author":"Onakpoya","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/09637486.2016.1196655","article-title":"Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans","volume":"67","author":"Momose","year":"2016","journal-title":"Int J Food Sci Nutr"},{"key":"R31-20230917","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3945\/ajcn.2009.27469","article-title":"Meta-analysis of the effects of flaxseed interventions on blood lipids","volume":"90","author":"Pan","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R32-20230917","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/ejcn.2010.178","article-title":"beta-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials","volume":"64","author":"AbuMweis","year":"2010","journal-title":"Eur J Clin Nutr"},{"key":"R33-20230917","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ajcn\/88.4.1167","article-title":"Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis","volume":"88","author":"Sood","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R34-20230917","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.phymed.2015.10.011","article-title":"Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data","volume":"23","author":"Cicero","year":"2016","journal-title":"Phytomedicine"},{"key":"R35-20230917","doi-asserted-by":"crossref","DOI":"10.2174\/1381612823666170317145851","article-title":"Nutraceuticals as an important part of combination therapy in dyslipidaemia","author":"Patti","year":"2017","journal-title":"Curr Pharma Design"},{"key":"R36-20230917","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.numecd.2009.05.017","article-title":"Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study","volume":"20","author":"Affuso","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R37-20230917","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1089\/jmf.2015.0024","article-title":"Testing the short-term efficacy of a lipid-lowering nutraceutical in the setting of clinical practice: a multicenter study","volume":"18","author":"Cicero","year":"2015","journal-title":"J Med Food"},{"key":"R38-20230917","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-511X-11-123","article-title":"Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment","volume":"11","author":"Pisciotta","year":"2012","journal-title":"Lipids Health Dis"},{"key":"R39-20230917","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijcme.2016.03.001","article-title":"The combination of nutraceutical and simvastatin enhances the effect of simvastatin alone in normalising lipid profile without side effects in patients with ischemic heart disease","volume":"11","author":"Campolongo","year":"2016","journal-title":"IJC Metab Endocrine"},{"key":"R40-20230917","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacl.2013.11.003","article-title":"Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus","volume":"8","author":"Ruscica","year":"2014","journal-title":"J Clin Lipidol"},{"key":"R41-20230917","doi-asserted-by":"crossref","first-page":"e101978","DOI":"10.1371\/journal.pone.0101978","article-title":"Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial","volume":"9","author":"Sola","year":"2014","journal-title":"PLoS One"},{"key":"R42-20230917","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.phrs.2016.04.021","article-title":"The effects of a nutraceutical combination on plasma lipids and glucose: a systematic review and meta-analysis of randomized controlled trials","volume":"110","author":"Pirro","year":"2016","journal-title":"Pharmacol Res"},{"key":"R43-20230917","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.arteri.2016.03.002","article-title":"Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials","volume":"28","author":"Millan","year":"2016","journal-title":"Clinica e investigacion en arteriosclerosis"},{"key":"R44-20230917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.003","article-title":"A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: review of the clinical evidence","volume":"24","author":"Barrios","year":"2017","journal-title":"Atheroscler Suppl"},{"key":"R45-20230917","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrcardio.2016.103","article-title":"Nutraceutical therapies for atherosclerosis","volume":"13","author":"Moss","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"R46-20230917","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1017\/S000711451200373X","article-title":"Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults","volume":"109","author":"Fuentes","year":"2013","journal-title":"Br J Nutr"},{"key":"R47-20230917","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jsfa.6467","article-title":"Lactobacillus plantarum CECT 7527, 7528 and 7529: probiotic candidates to reduce cholesterol levels","volume":"94","author":"Bosch","year":"2014","journal-title":"J Sci Food Agric"},{"key":"R48-20230917","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0043-100019","article-title":"Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"67","author":"Panahi","year":"2017","journal-title":"Drug Res (Stuttg)"},{"key":"R49-20230917","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1755-5922.2010.00179.x","article-title":"Nutraceuticals in diabetes and metabolic syndrome","volume":"28","author":"Davi","year":"2010","journal-title":"Cardiovasc Therap"},{"key":"R50-20230917","doi-asserted-by":"crossref","DOI":"10.5114\/aoms.2017.69326","article-title":"Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel","author":"Cicero","year":"2017","journal-title":"Arch Med Sci Nutr Rev"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201712000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T08:02:53Z","timestamp":1694937773000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201712000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000455","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}